Fatty acids differentially modify the expression of urokinase type plasminogen activator receptor in monocytes

Biochemical and Biophysical Research Communications

Volumn 376, Issue 1, 2008, Pages 196-199

  Assmann, Anke ^a,b   Möhlig, Matthias ^b   Osterhoff, Martin ^c   Pfeiffer, Andreas F H ^b,c   Spranger, Joachim ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Atherosclerosis; Free fatty acids; Monocytes macrophages; P38 MAP kinase; Urokinase type plasminogen activator receptor (uPAR)

Indexed keywords

FATTY ACID; LINOLEIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OLEIC ACID; PALMITIC ACID; PROTEIN KINASE C; UROKINASE RECEPTOR;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL LINE; FATTY ACIDS; HUMANS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PALMITATES; RECEPTORS, CELL SURFACE; UP-REGULATION;

EID: 52049127007     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.115     Document Type: Article

References (30)

1. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
2. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15 (1993) 105-111
3. Behrendt N. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Biol. Chem. 385 (2004) 103-136
4. Vassalli J.D., Baccino D., and Belin D. A cellular binding site for the Mr 55000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100 (1985) 86-92
5. Stoppelli M.P., Corti A., Soffientini A., Cassani G., Blasi F., and Assoian R.K. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA 82 (1985) 4939-4943
6. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3 (2002) 932-943
7. Simon D.I., Wei Y., Zhang L., Rao N.K., Xu H., Chen Z., Liu Q., Rosenberg S., and Chapman H.A. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275 (2000) 10228-10234
8. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., and Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269 (1994) 32380-32388
9. Colman R.W., Pixley R.A., Najamunnisa S., Yan W., Wang J., Mazar A., and McCrae K.R. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100 (1997) 1481-1487
10. Behrendt N., Jensen O.N., Engelholm L.H., Mortz E., Mann M., and Dano K. A urokinase receptor-associated protein with specific collagen binding properties. J. Biol. Chem. 275 (2000) 1993-2002
11. Mondino A., Resnati M., and Blasi F. Structure and function of the urokinase receptor. Thromb. Haemost. 82 Suppl. 1 (1999) 19-22
12. Steins M.B., Padro T., Schwaenen C., Ruiz S., Mesters R.M., Berdel W.E., and Kienast J. Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagul. Fibrinolysis 15 (2004) 383-391
13. May A.E., Schmidt R., Kanse S.M., Chavakis T., Stephens R.W., Schomig A., Preissner K.T., and Neumann F.J. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 100 (2002) 3611-3617
14. Moller D.E., and Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56 (2005) 45-62
15. Vessby B., Unsitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., Nälsén C., Berglund L., Louheranta A., Rasmussen B.M., Calvert G.D., Maffetone A., Pedersen E., Gustafsson I.B., and Storlien L.H. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44 (2001) 312-319
16. Hu F.B., Manson J.B., and Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J. Am. Coll. Nutr. 20 (2001) 5-19
17. Ralph P., Williams N., Moore M.A., and Litcofsky P.B. Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cell. Immunol. 71 (1982) 215-223
18. Brun T., Assimacopoulos-Jeannet F., Corkey B.E., and Prentki M. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46 (1997) 393-400
19. Lund L.R., Ronne E., Roldan A.L., Behrendt N., Romer J., Blasi F., and Dano K. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J. Biol. Chem. 266 (1991) 5177-5181
20. Rask-Madsen C., and King G.L. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 487-496
21. Way K.J., Chou E., and King G.L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21 (2000) 181-187
22. Yaqoob P., Knapper J.A., Webb D.H., Williams C.M., Newsholme E.A., and Calder P.C. Effect of olive oil on immune function in middle-aged men. Am. J. Clin. Nutr. 67 (1998) 129-135
23. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanim H., Aljada A., and Dandona P. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52 (2003) 2882-2887
24. Crunkhorn S., Dearie F., Mantzoros C., Gami H., da Silva W.S., Espinoza D., Faucette R., Barry K., Bianco A.C., and Patti M.E. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 282 (2007) 15439-15450
25. Lee K.H., Choi E.Y., Hyun M.S., and Kim J.R. Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line PC3MLN4. Exp. Mol. Med. 36 (2004) 57-64
26. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
27. de Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., and Mamelle N. Mediterranean diet traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99 (1999) 779-785
28. de Lorgeril M., and Salen P. The Mediterranean diet in secondary prevention of coronary heart disease. Clin. Invest. Med. 29 (2006) 154-158
29. Perona J.S., Cabello-Moruno R., and Ruiz-Gutierrez V. The role of virgin olive oil components in the modulation of endothelial function. J. Nutr. Biochem. 17 (2006) 429-445
30. Tsimikas S., Philis-Tsimikas A., Alexopoulos S., Sigari F., Lee C., and Reaven P.D. LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 122-130